© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Bupropion hydrochloride didn’t come from a trendy biotech startup or recent craze. The journey began in the late 1960s, driven by chemists determined to find antidepressant options with fewer drawbacks than tricyclic or monoamine oxidase inhibitors. Burroughs Wellcome (now part of GlaxoSmithKline) landed on bupropion in 1969. By the early 1980s, the compound moved from theoretical molecule to solid hope for patients after regulatory approval. Over the years, with patents expiring and the demand for mood disorder therapies climbing, its presence grew. Beyond depression, doctors found positive impacts on smoking cessation and even attention-deficit symptoms. Each new use brought research energy and regulatory reviews, prompting new formulations and deeper study into its risks.
On the shelf, bupropion hydrochloride arrives as a white to off-white crystalline powder. Pharmaceutical labs pack it into immediate-release, sustained-release, and extended-release tablets, each serving unique dosing needs. Unlike classic antidepressants, bupropion shuns sedation and sexual side effects, earning it a reputation as a go-to pick for those aiming to steer clear of those pitfalls. Marketed under names like Wellbutrin and Zyban, and shipped out by both generic and branded manufacturers, its versatility stands out. The availability stretches across the globe, with health authorities acknowledging its multi-pronged utility.
With a molecular formula of C13H18ClNO and a molecular weight of about 239.7 g/mol, bupropion hydrochloride stands out for its stability at standard storage conditions. It melts in the range of 233-238°C. Water solubility hovers around 30 mg/mL, giving pharmaceutical formulators enough leeway for predictable absorption. Chemists appreciate its robust structure, especially its resistance to photodegradation, so long as storage occurs away from direct light and moisture. Analytical chemists have consistently confirmed identity and purity using spectroscopy and chromatography because its chemical structure—3-chloro-N-tert-butyl-β-ketoamphetamine—provides consistent, quantifiable signals in testing.
In practical terms, pharmaceutical compendia such as USP and EP set identity, purity, and impurity limits. Tablet content, uniformity, dissolution, and shelf-life mark essential checkpoints for each batch. Most tablets carry 75 mg, 100 mg, or 150 mg, and clear labeling on packaging warns about contraindications, particularly the heightened risk of seizures at higher doses or with pre-existing risk factors. Labels are not just for regulatory compliance—they play a crucial role for patients and pharmacists as dosing errors can trigger serious events. Each bottle comes with clear warnings about interactions, notable side effects (insomnia, agitation, dry mouth), and guidance about alcohol use or co-administration with other drugs lowering seizure threshold.
Manufacturing bupropion hydrochloride involves reacting 3'-chloropropiophenone with tert-butylamine under controlled conditions. This yields racemic bupropion, which undergoes further purification steps to reach pharmaceutical grade. Converting it to the hydrochloride salt boosts stability and bioavailability. Finished products get compressed into tablets, sometimes with extended-release coatings or polymers to slow down absorption. Manufacturing lines rely on rigorous in-process checks—blend uniformity, tablet hardness, dissolution profiles—to guard against batch-to-batch variation. Each production cycle ends with analytical verification, packaging, and distribution to the supply chain.
Bupropion’s chemistry lies in its aromatic ketone backbone and tertiary butylamine group, offering plenty of targets for synthetic chemists. Modification of the aromatic ring or the N-alkyl side chain changes its pharmacology—these changes underpin research seeking similar drugs with different antidepressant or stimulant activities. The current commercial process tries to minimize environmental impact by selecting greener solvents and optimizing yields. Efforts in medicinal chemistry keep chasing new analogues with similar therapeutic promise and fewer side effects, showing bupropion's chemical flexibility keeps research rolling forward.
Over the decades, bupropion hydrochloride has worn many names in scientific and commercial circles. Popular brand names include Wellbutrin, Zyban, Aplenzin, Elontril, and Forfivo XL. In chemical trade literature, references often say amfebutamone or by its descriptive names—3-chloro-N-tert-butyl-beta-ketoamphetamine. Each synonym reflects a chapter in marketing or regulatory registration, adding to the web of information patients and professionals sift through while searching databases or prescribing.
Handling bupropion hydrochloride calls for attention to detail in both lab and manufacturing environments. Dust inhalation and skin contact are best avoided; protective gloves, eyewear, and local ventilation remain standard protocol. Chronic high-dose exposure, whether by accident or misuse, increases the risk for neuropsychiatric effects and convulsions. Pharmacies keep it away from young children and those with a history of eating disorders or seizures, as noted on prescribing guides. Robust post-marketing surveillance systems help regulators and clinicians spot rare side effects and update clinical recommendations. For the average patient, sticking close to prescribed doses and promptly reporting side effects keeps risks in check.
Though bupropion hydrochloride started life as an antidepressant, it expanded into smoking cessation after studies in the 1990s showed it helped people quit cigarettes by easing withdrawal symptoms. Off-label, clinicians saw benefits for attention-deficit symptoms in adults, weight management, and certain anxiety disorders, though these uses lack the same volume of data supporting the main indications. In practice, doctors pick bupropion for patients where sexual side effects, sedation, or weight gain from other antidepressants cause trouble. Insurance systems and formularies across dozens of countries now list bupropion among reimbursed drugs, making it a staple in pharmacies.
Scientists push the boundaries of bupropion research in several directions. Some aim to optimize dosing schedules or delivery mechanisms for patient convenience and adherence. Digital health tools now track real-world use and side effects, feeding large datasets back into post-marketing research. Preclinical groups screen bupropion analogues for activity against neurodegenerative diseases or investigate how the molecule’s structure influences downstream biological effects. Clinical trials continue for niche indications—seasonal affective disorder, bipolar depression, even chronic fatigue—although results vary. This persistent curiosity signals that even after decades, bupropion’s story isn’t finished.
Toxicological studies paint a clear picture: in therapeutic doses, bupropion hydrochloride delivers meaningful benefits, but pushing beyond those limits, intentionally or by mistake, turns serious quickly. Seizure remains the best-known danger, especially as dose climbs past 450 mg daily or mixes with other neurological risk factors. Animal toxicity studies show effects on liver enzymes and neurochemical pathways, providing context for human risk assessments. Post-marketing reports of rare allergic reactions, cardiovascular effects, or psychiatric changes prompt continuous examination from regulators and industry. Hospitals and poison control centers train to recognize and treat acute bupropion toxicity, using supportive care and sometimes anticonvulsants or activated charcoal. Public awareness campaigns encourage safe storage, especially for households with children or teenagers.
Bupropion hydrochloride stands at an interesting crossroads, as trends in psychiatry and neurology search for treatments that minimize side effects without sacrificing effectiveness. Next-generation delivery systems—microsphere injectables, multi-layer tablets—seek to flatten dosing curves and cut down on missed doses. Synthetic chemists still see value in the molecule’s framework, spinning out analogues with hopes of better targeting or longer patent protection. Regulatory agencies keep a close eye on real-world safety, as broader use in more patient groups might reveal new insights. Patient advocacy and education groups push for more research into mood disorders and addiction, ensuring the drug’s continued relevance. For every person who has found relief thanks to bupropion hydrochloride, the medicine’s legacy speaks to persistent scientific effort and the real-world pressures of living with mood disorders.
Bupropion Hydrochloride is a name you’ll probably hear if you get a prescription for depression, but that’s only the start of its story. Years ago, I first noticed it on a friend’s medicine shelf. She explained her doctor switched her from another antidepressant because she couldn’t handle the sluggishness. Bupropion, she told me, didn’t make her sleepy. That’s a big deal for people whose main struggle includes low energy and blank moods.
Doctors usually offer Bupropion for major depressive disorder and seasonal affective disorder. Depression doesn’t look the same in everyone; some lose motivation, others can’t concentrate or enjoy what they used to. Not all medications work the same way. Bupropion stands out here, with fewer sexual side effects and less weight gain compared to the older antidepressants like SSRIs or tricyclics. This makes it a more realistic option for people worried about those problems. The medication changes how your brain handles dopamine and norepinephrine, two chemicals that play a role in motivation and alertness.
Bupropion became more popular for another reason: kicking the smoking habit. Under the name Zyban, it helps people manage cravings and withdrawal. There’s research behind this—studies from the 1990s showed more people stayed smoke-free with Bupropion than with placebo. Nicotine dependence runs deep, not just in the body but in the mind. Bupropion gives smokers a leg up, especially when combined with support or counseling.
No medicine fits every person. Those with a history of seizures shouldn’t use Bupropion, since it can make seizures more likely. People with eating disorders face higher risk too. Every physician should screen for these conditions before starting the drug. Letting doctors know your full health story gives them the pieces to keep you safer.
This medication gives people more choices, but there’s a flipside. Some folks get anxious or jittery on it. Others notice trouble sleeping. These side effects can push people to stop taking it, which raises the risk of relapse. You’ll also hear about its possible link to increased blood pressure, so health care teams often check blood pressure more closely with this medicine than with some others.
Insurance coverage can throw up barriers too. I’ve seen people get frustrated by coverage denials or high co-pays for brand-name versions. The generic helps but costs still run up fast for some. Without affordable medication, consistency falters and treatment suffers. It’s more than a medical issue; healthcare policies and pharmacy access play into who actually benefits.
If more people felt comfortable talking about mental health, and if primary care clinics looked for depression and nicotine dependence regularly, we’d catch more folks before things snowball. Mental health workers and doctors do better when everyone can get reliable medications without break-the-bank prices. Clear information from pharmacists and honest talk about side effects set people up for success with Bupropion. Medications alone can’t fix everything, but matched with tools like therapy or group support, they bring hope to people who need it.
I’ve seen lives open up—not overnight, but day after day as the right treatment combinations take hold. For many, Bupropion Hydrochloride means more than a prescription; it’s a chance to reclaim some energy and agency, whether that’s fighting depression or putting cigarettes behind them for good.
Bupropion Hydrochloride landed on the scene as an antidepressant, but its popularity soared because it does more than just lift mood. Doctors use it for depression, quitting smoking, and sometimes even for low energy. This pill changes how nerves talk to each other by shifting the balance of dopamine and norepinephrine in the brain. Patients like it partly because it won’t make you gain weight the way some depression meds can, but any medication comes with trade-offs. Before anyone swallows their first dose, it’s helpful to know what to expect.
People taking bupropion often notice dry mouth. That pesky thirst isn’t just in your head—about one in ten folks feel their tongue almost glued to the roof of their mouth. This never feels good, and sipping water becomes second nature. There’s also insomnia, and that can’t be ignored. Trouble falling or staying asleep doesn’t just wreck a night or two—over time, dragging through the day tired can lead to mistakes at work, impatience with family, or even risky driving.
Sometimes the stomach churns, and people complain of nausea or stomach pain. I’ve had friends who needed to eat before every dose, otherwise they’d feel queasy. Even then, the upset might not disappear right away. Headaches come up too, adding pressure to daily life. Nobody likes a pounding head during a stressful week.
Bupropion gets talked about for energy and focus, but sometimes it overshoots that goal. Jitters and mild anxiety can make hands shake and nerves feel frayed. I spoke with colleagues who needed to cut back on caffeine just to keep their hearts from racing. Anxiety feels different for everyone, but any medication making it worse isn’t helpful.
Any list of side effects leads somewhere serious—seizures. This side effect scares people, and for good reason. The risk stays low at standard doses, but piles up if someone doubles up by accident, drinks heavily, or already has a tendency for seizures. I met a patient who switched from another antidepressant and wasn’t told to wait long enough; that overlap made things dicey for her. Honest, up-front communication with a doctor matters here.
Sometimes bupropion messes with mood. Some people get more irritable; others feel a burst of motivation. Rarely, a rush of energy turns into agitation or mania, especially for folks living with bipolar disorder. Hallucinations, confusion, or suicidal thoughts need medical attention right away. Mental health isn’t one-size-fits-all. It’s worth telling friends and family what to watch for, just in case small behavior shifts go unnoticed by the person taking the medication.
No one should face these side effects alone. Pharmacists can walk through risks in plain language. Doctors might start at a low dose and raise it slowly so the side effects don’t hit all at once. Some people find relief by changing when they take bupropion—early in the day instead of before bed. Others benefit from keeping track in a journal, noting moods and sleep patterns.
Everyone’s body speaks up in a different way. Reading a pharmacy leaflet helps, but listening to your own symptoms works better. If something feels off, tell someone. Most folks who stick with bupropion find the pros often beat the cons—especially with a little planning, patience, and teamwork with trusted health professionals.
Bupropion hydrochloride, mostly recognized by folks as Wellbutrin or Zyban, helps many people quit smoking or manage depression. Doctors usually prescribe it because it works on the brain’s chemical messengers, making things a bit easier when life feels heavy or cravings run strong. Every prescription comes with details, but getting real results means understanding the bigger picture, not just swallowing a pill at a fixed hour.
Every bottle of bupropion comes with instructions right there on the label, but I’ve seen many friends miss details, or skip steps out of impatience. Doctors and pharmacists often stress the need to take it the same way each day. If you start your morning with breakfast, keep your pill routine paired with food to remember it better. Skipping doses can throw off your progress. Doubling up just because you missed one keys up the risk for dangerous side effects, especially seizures. Bupropion isn’t like acetaminophen; the body needs steady levels for it to work well.
Some folks notice dry mouth, dizziness, or trouble sleeping. Years ago, my friend Ben tried it without talking with his doctor about his other medicines. Mixing in extra caffeine or taking decongestants gave him pounding headaches. These combinations can cause trouble. That’s why the pharmacy always runs those checks—drug interactions can throw a wrench in the works.
Bupropion has a unique structure compared to many depression or smoking-cessation medications. It doesn’t belong to the SSRI family. It’s got its own quirks. My family’s pharmacist once explained that taking all doses too close together makes seizures more likely. That fact isn’t just a technical warning—the risk stays real. The numbers tell the story: studies show seizure risk rises as daily doses go up, especially above 450 mg per day. This isn’t a small increase; it can go up up to tenfold versus lower doses.
Doctors don’t just guess the starting dose. They look at your history, current medications, even kidney or liver function. At my clinic, adjustments often happen after just a week or two. People sometimes want to quit early after a rough patch in the first week. That period can feel rough, but quick changes make things worse. Your doctor can help sort out whether symptoms come from the medicine, interactions, or life stress. Self-adjusting the dose doesn’t get you faster results, just extra headaches.
Routine counts. Pairing the medication with something like brushing your teeth or breakfast sticks the habit. Setting an alarm or reminder on your phone helps. Watch for changes in your mood or energy. Write them down. Bring those notes to your doctor. Honest feedback helps find the right balance. If you ever feel strange symptoms—confusion, racing heart, or chest pain—that deserves a call to the clinic or ER, no exceptions.
Don’t crush or chew the tablets, even if swallowing pills feels inconvenient. Crushing releases the medicine all at once. That shortcut puts you at a much higher risk of seizures and side effects. Only use the long-acting or extended-release forms as directed.
From my own experience and seeing loved ones struggle, cutting corners rarely ends well. The best progress comes from honest conversations with your doctor, steady routines, and taking each step with patience—not shortcuts. Bupropion can open a door, but you need a steady hand to walk through it.
Bupropion Hydrochloride lands on prescription pads for lots of reasons, usually to help people with depression or keep them smoke-free. It stands out as different from many antidepressants, but it’s not immune to trouble with other meds. Out in the real world, people rarely take just one pill a day. Mixing medicines has become common, thanks to rising rates of chronic illness. Folks juggling diabetes, heart issues, depression, and anxiety don’t have room for surprises. That’s why understanding interactions isn’t some niche topic—it matters for daily life.
Whenever I talk to someone starting bupropion, I ask about seizure history. Bupropion raises that risk, and if someone’s got other meds piling onto that danger, things get risky fast. Antidepressants like sertraline or citalopram often show up together in pill sorters. Rare isn’t the right word when you see how many folks have tried several mood meds in the past. Some drugs, like SSRI antidepressants or antipsychotics, already lower the seizure threshold. Pile bupropion on top and the odds tilt further. Even a history of heavy drinking or abrupt alcohol withdrawal stacks the risk.
Certain combinations mess with the way drugs break down in the body. Bupropion competes for the liver’s attention, specifically a system known as CYP2B6 and CYP2D6. That might sound technical, but it’s really about how long medicine hangs around. If someone takes medications like tamoxifen, metoprolol, or even over-the-counter antihistamines, bupropion can slow down or speed up how these drugs leave the body. I’ve seen people feel dizzy, agitated, or get heart pounding out of the blue, all because of these hidden fights between drugs.
Years at the pharmacy counter taught me that people rarely mention herbal supplements or vitamins unless I ask. St. John’s Wort, a popular pick for mood, can mess up the effectiveness of bupropion and other treatments, often reducing how well they work. Grapefruit juice sometimes shows up as a wild card. It blocks the breakdown of medications in the gut and liver, sometimes causing side effects to skyrocket.
Nobody wants a surprise seizure, or their blood pressure spiking out of nowhere. Keeping track of all medicines—prescription or not—keeps the chance of disaster low. Handwritten notes, lists on a phone, or even apps like Medisafe make a difference. Telling your doctor and pharmacist the whole story, even the stuff that seems too minor, keeps you safer. I’ve seen people embarrassed to admit using supplements their doctor “doesn’t like” or skipping a dose. Truth is, doctors have seen it all. They care more about safety than passing judgment.
Improving medication safety starts with open communication. Pharmacists can catch hidden problems, but only if they know what a person’s taking. Technology in electronic medical records now flags common bupropion interactions, but nothing replaces the value of a real-life conversation. Patients should update their medication list every time something changes. If a new symptom pops up—like shakes, sweats, headaches—it’s better to check than ignore it. Treatment with bupropion can work wonders, as long as the rest of the medication puzzle fits in safely.
Pregnancy brings a mix of excitement and anxiety. Countless decisions pile up, and medication safety leads the list. Bupropion Hydrochloride helps with depression, seasonal affective disorder, and quitting smoking. Still, the safety decision gets messier once a child enters the picture. Doctors and mothers face a tough call because untreated depression itself brings risks—preterm birth, low birth weight, and developmental issues in a growing baby. But medicines also raise fear, especially since no pill completely escapes risk.
Bupropion does not sit in the same league as older drugs with a long record during pregnancy, yet plenty of pregnant women have taken it. Studies of bupropion in pregnancy have not found clear signs of birth defects. One large study published in American Journal of Obstetrics & Gynecology looked at over 1,000 pregnant women who took bupropion and didn’t find higher rates of malformations compared to those who avoided it. Still, small signals show up sometimes—like a possible slight increase for some specific heart defects—meaning the science is not airtight. These signals do not prove cause and effect, but they raise caution. A health choice that only takes statistics into account and ignores the real-life impact on mental health can do more harm than good.
Moms need to remember their well-being matters. Doctors often use bupropion during pregnancy if other treatments fail or side effects from other antidepressants grow worse. Obstetricians and psychiatrists sometimes weigh the risks using tools like the “risk-benefit” assessment, a simple conversation that covers both risks of the medicine and the cost of untreated depression. After close conversations with more than one doctor, many mothers find the lowest effective dose and the safest plan.
No medicine can offer a “100% safe” stamp of approval. Antidepressants like SSRIs and SNRIs get prescribed more often because of broader data and more experience, but bupropion gets a nod when those options come up short. Direct experience with close friends shows that mental health affects every part of a pregnancy—healthier decisions, better sleep, and honest talks with medical providers.
Feeding a newborn is full of complex decisions, and mothers juggle their own recovery with a baby’s early needs. Small amounts of bupropion pass into breastmilk—roughly 1% to 2% of the maternal dose—which sounds tiny, but the newborn’s body takes in drugs differently than adults. Reports exist of infants who felt irritable or had mild seizures, although such cases aren’t common. The American Academy of Pediatrics doesn’t call bupropion an automatic no-go, but they ask for careful watching. New mothers who take bupropion and breastfeed should look for unusual fussiness, poor feeding, or sleep changes in their infants and talk with pediatricians straight away.
The best approach always values shared decision-making. A trusted provider checks symptoms, medical history, and details about the pregnancy before signing off on any medicine. Families support better outcomes when stigma goes out the window and mothers receive support instead. Clear guidance on mental health wins the day, not guessing or hiding. Options exist—talk therapies, lifestyle changes, social support—but some mothers need medicine to keep up with life or even stay safe.
| Names | |
| Other names |
Amfebutamone Zyban Wellbutrin Wellbutrin SR Wellbutrin XL Aplenzin Forfivo XL Budeprion Buproban |
| Pronunciation | /bjuːˈproʊ.pi.ˌɑːn haɪˈdrɑː.klə.raɪd/ |
| Identifiers | |
| CAS Number | 31677-93-7 |
| Beilstein Reference | 1228955 |
| ChEBI | CHEBI:4447 |
| ChEMBL | CHEMBL682 |
| ChemSpider | 110014 |
| DrugBank | DB01156 |
| ECHA InfoCard | echa.europa.eu/infocard/100.223.234 |
| EC Number | 130209-22-8 |
| Gmelin Reference | 88308 |
| KEGG | D07541 |
| MeSH | D019821 |
| PubChem CID | 62241 |
| RTECS number | EJ4200000 |
| UNII | 01ZG3TPX31 |
| UN number | UN3249 |
| CompTox Dashboard (EPA) | DTXSID4046848 |
| Properties | |
| Chemical formula | C13H19Cl2NO |
| Molar mass | 276.2 g/mol |
| Appearance | White or almost white, crystalline powder |
| Odor | Odorless |
| Density | 1.2 g/cm3 |
| Solubility in water | Freely soluble in water |
| log P | 2.0 |
| Acidity (pKa) | 7.9 |
| Basicity (pKb) | 8.5 |
| Magnetic susceptibility (χ) | -76.6×10-6 cm3/mol |
| Refractive index (nD) | 1.613 |
| Dipole moment | 4.67 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 395.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -276.0 kJ/mol |
| Pharmacology | |
| ATC code | N06AX12 |
| Hazards | |
| Main hazards | May cause neuropsychiatric reactions, seizures, hypersensitivity reactions, and increased blood pressure. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | ["Rx", "Oral", "Tablet"] |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. H312: Harmful in contact with skin. H332: Harmful if inhaled. |
| Precautionary statements | Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. |
| NFPA 704 (fire diamond) | 1-2-0- |
| Flash point | Flash point: 244.9°C |
| Autoignition temperature | Autoignition temperature: 410°C |
| Lethal dose or concentration | LD₅₀ (oral, rat): 496 mg/kg |
| LD50 (median dose) | Mouse oral LD50 is 210 mg/kg |
| NIOSH | NM8723010 |
| PEL (Permissible) | PEL: Not established |
| REL (Recommended) | 150 mg |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Bupropion Bupropion hydrobromide Bupropion sulfate Hydroxybupropion Erythrohydrobupropion Threohydrobupropion |
